Atlas Trials

Safety and Immunogenicity of a Pneumococcal Conjugate Vaccine Candidate in Healthy Adults (19-49 Years)

Clinical trial NCT06698198 · COMPLETED

Trial details

NCT number
NCT06698198
Sponsor
Sanofi Pasteur, a Sanofi Company
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Pneumococcal Immunization
Start date
2018-12-03
Primary completion
2019-09-30
Enrollment
175

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.